Back to Search
HOPE BROXTERMAN, PHARMD
PHARMD
Pharmacist
NPI: 1912349978Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Cancer research 2000: drug resistance, new targets and drugs in development.
PMID 11498376·Drug Resist Updat·2000
8-other
Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib.
PMID 19212818·Angiogenesis·2009
8-other
Sunitinib-induced hemoglobin changes are related to the dosing schedule.
PMID 19188672·J Clin Oncol·2009
7-preclinical
Sunitinib-induced myeloid lineage redistribution in renal cell cancer patients: CD1c+ dendritic cell frequency predicts progression-free survival.
PMID 18794101·Clin Cancer Res·2008
8-other
Angiogenesis inhibitors. Drug selectivity and target specificity.
PMID 17897024·Curr Pharm Des·2007
6-review
VEGFR2 expressing circulating (progenitor) cell populations in volunteers and cancer patients.
PMID 17721629·Thromb Haemost·2007
8-other
Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation.
PMID 17097285·Eur J Cancer·2007
7-preclinical
CD13/Aminopeptidase N overexpression by basic fibroblast growth factor mediates enhanced invasiveness of 1F6 human melanoma cells.
PMID 16685268·Br J Cancer·2006
8-other
Anticancer therapeutics: "Addictive" targets, multi-targeted drugs, new drug combinations.
PMID 16154800·Drug Resist Updat·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 1105 SIXTH ST
TRAVERSE CITY, MI 49684 - Phone
- (231) 935-5000
Quick Facts
- NPI
- 1912349978
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile